Cite
MLA Citation
M. Matasar et al.. “POLATUZUMAB VEDOTIN PLUS BENDAMUSTINE AND RITUXIMAB OR OBINUTUZUMAB IN RELAPSED/REFRACTORY FL OR DLBCL: UPDATED RESULTS OF A PHASE 1B/2 STUDY.” Hematological oncology, vol. 35, n.d., pp. 271–272. http://access.bl.uk/ark:/81055/vdc_100047428638.0x00001e